Crohn disease
What it is
IBD comprises a group of related conditions characterized by idiopathic inflammation of the GI tract, and the two most common are Crohn's disease and ulcerative colitis, both of which cause macroscopic inflammation. Crohn's disease can involve any part of the GI tract: small bowel with colon in 50%, small bowel only in 30%, and colon only in 20%. The involvement is transmural, with skip lesions. Several features may differentiate it from ulcerative colitis, but the overlap is significant.
Causes and risk
Smoking is a risk factor for the disease, while in ulcerative colitis smoking alleviates symptoms.
How it presents
Abdominal pain is prominent, with diarrhea, inflammatory masses, fever, weight loss, and intestinal strictures and fistula to skin, bladder, vagina, or enteric-enteric. The pain is post-prandial and colicky. Diarrhea is less prevalent than in ulcerative colitis, large in volume, watery, and usually non-bloody, though it may be bloody, particularly if there is distal colonic involvement. A palpable mass is frequent, in about 25%, in the RLQ. The most common extraintestinal manifestations are oral aphthous ulcers, arthralgia, and back pain indicating ankylosing spondylitis or sacroiliitis; eye redness, pain and swelling may result from uveitis or scleritis; skin manifestations include pyoderma gangrenosum and erythema nodosum; and liver involvement most commonly includes PSC.
How it is diagnosed
Colonoscopy and biopsy confirm the diagnosis. Endoscopic features are segmental, patchy inflammation with aphthous, stellate, linear or serpiginous ulcerations, skip areas, pseudopolyps and cobblestoning. Histologic features are focal inflammation with transmural distribution, noncaseating granulomas that are characteristic but often not found, deep fissuring with aphthous ulcerations, strictures, and intact glands. Radiologic features are cobblestone mucosa and bowel wall thickening giving the string sign. Fecal calprotectin is a useful non-invasive biomarker for IBD activity and for distinguishing IBD from IBS, and CRP and ESR are the inflammatory markers used in monitoring. The endoscopic tests for active small bowel Crohn's disease are capsule endoscopy, colonoscopy with ileoscopy, CT enterography and small bowel follow-through, and they are also used in pairs, capsule endoscopy plus colonoscopy with ileoscopy or capsule endoscopy plus CT enterography. Disease activity is described by formal grading systems, and two commonly used ones are the Crohn's Disease Activity Index (CDAI) and the Harvey-Bradshaw Index (HBI). A low-risk patient with mild Crohn disease is one with no or mild symptoms, a normal or mild elevation in C-reactive protein or fecal calprotectin, diagnosis at age over 30 years, limited distribution of bowel inflammation, superficial or no ulceration on colonoscopy, no perianal complications, no prior intestinal resections, and no penetrating or stricturing disease.
On barium the narrowed segment has a name of its own. A double-contrast barium enema may demonstrate a focal narrowing, in the sigmoid colon, with rolled, heaped up shoulders resulting in a severe stenosis — the apple-core stenosis — while the remainder of the imaged colon appears normal in caliber and lined by normal mucosa. In an elderly patient the apple core sign means colorectal cancer first, but the appearance of the apple-core lesion of the colon can also be caused by lymphoma with colonic involvement, which appears more diffuse, by Crohn disease, by chronic ulcerative colitis, by ischemic colitis, by chlamydia infection, by colonic tuberculosis and by colonic amoebiasis. So the sign does not on its own separate this disease from malignancy; the age and the rest of the picture do.